Share on twitter
Share on LinkedIn
Share on Facebook
Email to a friend
Print page
This CEU Statement provides guidance to healthcare professionals in response to a letter circulated by MSD (manufacturer of Nexplanon®) to healthcare professionals in the UK about updated guidance regarding the recommended Nexplanon® insertion site.
Certificate of Attendance for the CSRH Development Day held on Thursday 3 December 2020.
Our FSRH CEU statement examines the available evidence and provides recommendations in relation to the association between cerebral venous sinus thrombosis, AstraZeneca COVID-19 vaccination and combined hormonal contraception.
Download our FSRH brand guidelines, last updated in February 2021.
Download slides from our Progestogen-only Implant guideline webinar, which took place on 31 March 2021.
FSRH response to NHS Confederation survey on leadership in Integrated Care Systems
A certificate for attendees of our Progestogen-only Implant guideline webinar event on March 31, 2021.
Report launched by the Northern Ireland Abortion and Contraception Taskgroup (NIACT). NIACT is a group of multidisciplinary professionals formed in response to the Abortion (Northern Ireland) Regulations 2020. The purpose of NIACT's report is to provide an evidence base to inform the funding and commissioning of Relationships and Sexuality Education (RSE) provision and integrated sexual and reproductive healthcare for the population of Northern Ireland.
presentation on new assessment in the updated csrh 2021
Formative OSATS Form
CSRH workplace based assessments
